These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38215341)

  • 1. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges.
    Bayoumy S; Verberk IMW; Vermunt L; Willemse E; den Dulk B; van der Ploeg AT; Pajkrt D; Nitz E; van den Hout JMP; van der Post J; Wolf NI; Beerepoot S; Groen EJN; Tüngler V; Teunissen CE
    Clin Chem Lab Med; 2024 Jun; 62(7):1252-1265. PubMed ID: 38215341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children.
    Nitz E; Smitka M; Schallner J; Akgün K; Ziemssen T; von der Hagen M; Tüngler V
    Ann Clin Transl Neurol; 2021 Oct; 8(10):2013-2024. PubMed ID: 34482646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
    Wurster CD; Steinacker P; Günther R; Koch JC; Lingor P; Uzelac Z; Witzel S; Wollinsky K; Winter B; Osmanovic A; Schreiber-Katz O; Al Shweiki R; Ludolph AC; Petri S; Hermann A; Otto M;
    J Neurol; 2020 Jan; 267(1):36-44. PubMed ID: 31552549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
    Rich KA; Fox A; Yalvac M; Heintzman S; Tellez M; Bartlett A; Severyn S; Linsenmayer M; Kelly K; Reynolds J; Sterling GB; Weaver T; Rajneesh K; Pino MG; Arnold WD; Elsheikh B; Kolb SJ
    J Neuromuscul Dis; 2022; 9(1):111-119. PubMed ID: 34776417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the neurofilament light chain as a biomarker in children with spinal muscular atrophy treated with nusinersen.
    Seo G; Kim S; Byun JC; Kwon S; Lee YJ
    Brain Dev; 2023 Nov; 45(10):554-563. PubMed ID: 37541812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy.
    Spicer C; Lu CH; Catapano F; Scoto M; Zaharieva I; Malaspina A; Morgan JE; Greensmith L; Muntoni F; Zhou H
    Ann Clin Transl Neurol; 2021 Apr; 8(4):866-876. PubMed ID: 33683023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.
    Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY
    Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples.
    Abiusi E; Infante P; Cagnoli C; Lospinoso Severini L; Pane M; Coratti G; Pera MC; D'Amico A; Diano F; Novelli A; Spartano S; Fiori S; Baranello G; Moroni I; Mora M; Pasanisi MB; Pocino K; Le Pera L; D'Amico D; Travaglini L; Ria F; Bruno C; Locatelli D; Bertini ES; Morandi LO; Mercuri E; Di Marcotullio L; Tiziano FD
    Elife; 2021 Sep; 10():. PubMed ID: 34542403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.
    Glascock J; Darras BT; Crawford TO; Sumner CJ; Kolb SJ; DiDonato C; Elsheikh B; Howell K; Farwell W; Valente M; Petrillo M; Tingey J; Jarecki J
    J Neuromuscul Dis; 2023; 10(5):937-954. PubMed ID: 37458045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFL is a marker of treatment response in children with SMA treated with nusinersen.
    Olsson B; Alberg L; Cullen NC; Michael E; Wahlgren L; Kroksmark AK; Rostasy K; Blennow K; Zetterberg H; Tulinius M
    J Neurol; 2019 Sep; 266(9):2129-2136. PubMed ID: 31123861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy.
    Alves CRR; Zhang R; Johnstone AJ; Garner R; Nwe PH; Siranosian JJ; Swoboda KJ
    Neurology; 2020 Mar; 94(9):e921-e931. PubMed ID: 31882526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac function evaluation in children with spinal muscular atrophy: A case-control study.
    He X; Li X; Yan M; Peng H; Zhang L; Liang Y; Tang W; Li S
    Pediatr Int; 2024; 66(1):e15769. PubMed ID: 38742693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy.
    D'Amico A; Mercuri E; Tiziano FD; Bertini E
    Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased systemic HSP70B levels in spinal muscular atrophy infants.
    Eichelberger EJ; Alves CRR; Zhang R; Petrillo M; Cullen P; Farwell W; Hurt JA; Staropoli JF; Swoboda KJ
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1495-1501. PubMed ID: 33991176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Spinal Muscular Atrophy: A Simple Method for Quantifying the Relative Amount of Survival Motor Neuron Gene 1/2 Using Sanger DNA Sequencing.
    Cao YY; Zhang WH; Qu YJ; Bai JL; Jin YW; Wang H; Song F
    Chin Med J (Engl); 2018 Dec; 131(24):2921-2929. PubMed ID: 30539904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
    Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
    Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
    Czech C; Tang W; Bugawan T; Mano C; Horn C; Iglesias VA; Fröhner S; Zaworski PG; Paushkin S; Chen K; Kremer T
    PLoS One; 2015; 10(10):e0139950. PubMed ID: 26468953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
    Wilke C; Reich S; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Frisoni G; Ghidoni R; Sorbi S; Bocchetta M; Todd E; Kuhle J; Barro C; ; Rohrer JD; Synofzik M
    Ann Neurol; 2022 Jan; 91(1):33-47. PubMed ID: 34743360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament as a potential biomarker for spinal muscular atrophy.
    Darras BT; Crawford TO; Finkel RS; Mercuri E; De Vivo DC; Oskoui M; Tizzano EF; Ryan MM; Muntoni F; Zhao G; Staropoli J; McCampbell A; Petrillo M; Stebbins C; Fradette S; Farwell W; Sumner CJ
    Ann Clin Transl Neurol; 2019 May; 6(5):932-944. PubMed ID: 31139691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.